Drug-Induced Kidney Injury: How to Reduce the Risk of Vancomycin AKI скачать в хорошем качестве

Drug-Induced Kidney Injury: How to Reduce the Risk of Vancomycin AKI

Drug-induced kidney injury—especially vancomycin nephrotoxicity and vancomycin AKI or acute kidney injury—is a major patient safety problem for hospitals. InsightRX Nova is a precision dosing tool that helps clinicians maximize vancomycin’s clinical efficacy while minimizing the risk of AKI.* In this video, you’ll learn about the specific benefits of precision dosing for vancomycin and how InsightRX Nova helps reduce vancomycin-associated AKI events. Read the blog post: Precision Dosing: 7 Ways InsightRX Is Leading the Pack https://www.insight-rx.com/post/preci... Here you’ll find links to any studies mentioned in this video: • The Nephrotoxicity of Vancomycin https://www.ncbi.nlm.nih.gov/pmc/arti... • How Pharmacists are Reacting to New Vancomycin Dosing Guidelines https://content.insight-rx.com/vanco-... • New Vancomycin Dosing Guidelines    • New Vancomycin Dosing Guidelines [2020]: W...   • InsightRX Case Study - OSF HealthCare https://content.insight-rx.com/casest... • Cost of Acute Kidney Injury in Hospitalized Patients https://pubmed.ncbi.nlm.nih.gov/28182... InsightRX Nova precision dosing software has been shown in studies to accurately predict pharmacokinetics and improve clinical target attainment for various drugs. The relationship between clinical targets and efficacy and safety is defined by the drug label or is supported by published clinical studies or guidelines for each respective drug.